Stephen Hanauer to Sickness Impact Profile
This is a "connection" page, showing publications Stephen Hanauer has written about Sickness Impact Profile.
Connection Strength
0.103
-
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol. Aliment Pharmacol Ther. 2011 May; 33(10):1143-51.
Score: 0.095
-
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease. Dig Dis Sci. 1995 May; 40(5):931-5.
Score: 0.008